Aptamer-based strategies for glioblastoma: From SELEX to preclinical success.

Glioblastoma presents a persistent therapeutic challenge due to extensive intratumoral heterogeneity and the blood-brain barrier. Nucleic acid aptamers offer an effective alternative to overcome these physiological obstacles where conventional modali…

Preview only. Read the full abstract at the source